{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:12:59Z","timestamp":1785442379572,"version":"3.56.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS051398"],"award-info":[{"award-number":["NS051398"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS071597"],"award-info":[{"award-number":["NS071597"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21-NS076426"],"award-info":[{"award-number":["R21-NS076426"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21-NS099009"],"award-info":[{"award-number":["R21-NS099009"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01-NS083460"],"award-info":[{"award-number":["U01-NS083460"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01-NS117209"],"award-info":[{"award-number":["U01-NS117209"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01-NS117278"],"award-info":[{"award-number":["U01-NS117278"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.neuropharm.2021.108571","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T16:39:49Z","timestamp":1618763989000},"page":"108571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-9550","authenticated-orcid":false,"given":"Doodipala Samba","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Zaayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Kuruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108571_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/10408444.2016.1220916","article-title":"Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review","volume":"46","author":"Abou-Donia","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108571_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hipo.1060","article-title":"Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy","volume":"11","author":"Andre","year":"2001","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2021.108571_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302","volume":"351","author":"Apland","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib6","series-title":"Acetylcholinesterase Inhibitors (Nerve Agents) as Weapons of Mass Destruction: History, Mechanisms of Action, and Medical Countermeasures","first-page":"108298","author":"Aroniadou-Anderjaska","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108571_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neuro.2009.06.011","article-title":"Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus","volume":"30","author":"Aroniadou-Anderjaska","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2019.11.020","article-title":"Screening for efficacious anticonvulsants and neuroprotectants in delayed treatment models of organophosphate-induced status epilepticus","volume":"425","author":"Barker","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108571_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(03)00493-2","article-title":"Atropine, an anticholinergic drug, impairs memory retrieval of a high consolidated avoidance response in mice","volume":"345","author":"Boccia","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108571_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108571_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.neuropharm.2021.108571_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1081\/DCT-120030727","article-title":"Pharmacokinetic studies of intramuscular midazolam in Guinea pigs challenged with soman","volume":"27","author":"Capacio","year":"2004","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuro.2012.03.011","article-title":"Organophosphate-induced brain damage, mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies","volume":"33","author":"Chen","year":"2012","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108571_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.117.246660","article-title":"3\u03b2-Methyl-neurosteroid analogs are preferential positive allosteric modulators and direct activators of extrasynaptic \u03b4GABA-A receptors in the hippocampus dentate gyrus subfield","volume":"365","author":"Chuang","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib16","first-page":"145","volume":"vol. 75","author":"Crawshaw","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108571_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"de Araujo Furtado","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl. 9","key":"10.1016\/j.neuropharm.2021.108571_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABA-A receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/toxsci\/kfq157","article-title":"Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate","volume":"116","author":"Deshpande","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(02)35007-6","article-title":"The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus","volume":"135","author":"Dudek","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108571_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuro.2014.06.001","article-title":"4R-cembranoid protects against diisopropylfluorophosphate-mediated neurodegeneration","volume":"44","author":"Ferchmin","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.110.171835","article-title":"The GluK1 (GluR5) Kainate\/AMPA receptor antagonist LY293558 reduces soman-induced seizures and neuropathology","volume":"336","author":"Figueiredo","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12974-016-0744-y","article-title":"Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication","volume":"13","author":"Flannery","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2021.108571_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(96)00203-X","article-title":"The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus","volume":"725","author":"Fujikawa","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline, treatment of convulsive status epilepticus in children and adults, report of the guideline committee of the American epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Current"},{"key":"10.1016\/j.neuropharm.2021.108571_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-1211(01)00272-8","article-title":"Repeated low-dose treatment of rats with pilocarpine, low mortality but high proportion of rats developing epilepsy","volume":"46","author":"Glien","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2015.00196","article-title":"Neurostereology protocol for unbiased quantification of neuronal injury and neurodegeneration","volume":"7","author":"Golub","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib30","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/j.1528-1167.2009.02257.x","article-title":"The impact of diazepam's discovery on the treatment and understanding of status epilepticus","volume":"50","author":"Goodkin","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib31","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA-A receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1528-1157.2003.62402.x","article-title":"Diazepam terminates brief but not prolonged seizures in young, naive rats","volume":"44","author":"Goodkin","year":"2003","journal-title":"Epilepsia"},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2021.108571_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1528-1167.2007.01297.x","article-title":"GABA-A receptor internalization during seizures","volume":"48","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib34","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABA-A receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hipo.450040409","article-title":"Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection","volume":"4","author":"Gruber","year":"1994","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2021.108571_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuro.2006.01.007","article-title":"Nicotinic mechanisms contribute to soman-induced symptoms and lethality","volume":"27","author":"Hassel","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib37","first-page":"1","article-title":"Acute seizures in old age leads to a greater loss of CA1 pyramidal neurons, an increased propensity for developing chronic TLE and a severe cognitive dysfunction","volume":"2","author":"Hattiangady","year":"2011","journal-title":"Aging Dis"},{"key":"10.1016\/j.neuropharm.2021.108571_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuro.2017.11.009","article-title":"A magnetic resonance imaging study of early brain injury in a rat model of acute DFP intoxication","volume":"66","author":"Hobson","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/toxsci\/kfx049","article-title":"Magnetic resonance imaging reveals progressive brain injury in rats acutely intoxicated with diisopropylfluorophosphate","volume":"157","author":"Hobson","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40265-017-0859-1","article-title":"Pharmacotherapy for refractory and super-refractory status epilepticus in adults","volume":"78","author":"Holtkamp","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2021.108571_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1513\/pats.201001-003SM","article-title":"The CounterACT Research Network, basic mechanisms and practical applications","volume":"7","author":"Jett","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.neuropharm.2021.108571_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepine in the rat Li-Pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2017.03.017","article-title":"Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus","volume":"103","author":"Joshi","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"22","key":"10.1016\/j.neuropharm.2021.108571_bib44","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108571_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0091-3057(82)90485-3","article-title":"Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats","volume":"17","author":"Kenley","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108571_bib46","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1523\/JNEUROSCI.23-06-02440.2003","article-title":"Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy","volume":"23","author":"Kobayashi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1528-1157.1996.tb00039.x","article-title":"Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus","volume":"37","author":"Krishnamurthy","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024493","article-title":"Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity","volume":"6","author":"Kuruba","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108571_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.05.016","article-title":"Benzodiazepine-refractory status epilepticus, neuroinflammatiion, and neurodegeneration after acute organophosphate intoxication","volume":"1864","author":"Kuruba","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2021.108571_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/epi.13972","article-title":"Electroencephalography and behavior patterns during experimental status epilepticus","volume":"59","author":"Lewczuk","year":"2018","journal-title":"Epilepsia"},{"issue":"64","key":"10.1016\/j.neuropharm.2021.108571_bib53","first-page":"1","article-title":"Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2021.108571_bib55","first-page":"90","article-title":"Spatiotemporal patterns of GFAP upregulation in rat brain following acute intoxication with diisopropylfluorophosphate (DFP)","volume":"3","author":"Liu","year":"2012","journal-title":"Curr Neurobiol"},{"issue":"12","key":"10.1016\/j.neuropharm.2021.108571_bib56","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/epi.14582","article-title":"Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam","volume":"59","author":"Marrero-Rosado","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib57","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(98)00606-4","article-title":"Self-sustaining status epilepticus after brief electrical stimulation of the perforant path","volume":"801","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2021.108571_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002040050637","article-title":"Comparative evaluation of benzodiazepines for control of soman-induced seizures","volume":"73","author":"McDonough","year":"1999","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in Guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-7843.2008.00326.x","article-title":"Comparison of the intramuscular, intranasal or sublingual routes of midazolam administration for the control of soman-induced seizures","volume":"104","author":"McDonough","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.116.1.201","article-title":"NeuN, a neuronal specific nuclear protein in vertebrates","volume":"116","author":"Mullen","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2021.108571_bib68","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA-A receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2021.108571_bib69","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.yebeh.2019.06.011","article-title":"Early polytherapy for benzodiazepine-refractory status epilepticus","volume":"101","author":"Niquet","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108571_bib70","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2021.108571_bib71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.114.214932","article-title":"Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds","volume":"350","author":"Pereira","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/nyas.13137","article-title":"Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents","volume":"1378","author":"Pessah","year":"2016","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neuropharm.2021.108571_bib73","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuro.2016.08.002","article-title":"A rodent model of human organophosphate exposure producing status epilepticus and neuropathology","volume":"56","author":"Pouliot","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuro.2013.06.006","article-title":"Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure","volume":"38","author":"Prager","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib75","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuropharm.2014.01.035","article-title":"The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior","volume":"81","author":"Prager","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00726-008-0227-2","article-title":"Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis","volume":"38","author":"Qashu","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2021.108571_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-15-47","article-title":"Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes","volume":"15","author":"RamaRao","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jnr.20802","article-title":"Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy","volume":"83","author":"Rao","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108571_bib80","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.37285\/ijpsn.2020.13.6.1","article-title":"Clinical pharmacology and therapeutics of antiepileptic drugs for epilepsy and seizure disorders","volume":"13","author":"Reddy","year":"2020","journal-title":"Int J Pharm Sci Nanotechnology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cotox.2019.08.001","article-title":"Mechanism-based novel antidotes for organophosphate neurotoxicity","volume":"14","author":"Reddy","year":"2019","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.neuropharm.2021.108571_bib83","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cts.12435","article-title":"A comparative toxidrome analysis of human organophosphate and nerve agent poisonings using social media","volume":"10","author":"Reddy","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.neuropharm.2021.108571_bib84","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.3390\/ijms140918284","article-title":"Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions","volume":"14","author":"Reddy","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2021.108571_bib86","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/epi.14693","article-title":"Extrasynaptic GABA-A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures","volume":"60","author":"Reddy","year":"2019","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neuropharm.2021.108571_bib87","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/epi4.12389","article-title":"Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury","volume":"5","author":"Reddy","year":"2020","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108571_bib88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/nyas.14431","article-title":"Magnetic resonance imaging analysis of long-term neuropathology after exposure to the nerve agent soman: correlation with histopathology and neurological dysfunction","volume":"1480","author":"Reddy","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib89","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication-A pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib90","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/jpet.114.222075","article-title":"Antiseizure activity of midazolam in mice lacking delta-subunit extrasynaptic GABA-A receptors","volume":"353","author":"Reddy","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuropharm.2015.01.017","article-title":"Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus","volume":"93","author":"Rojas","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib94","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1023\/A:1024960819430","article-title":"Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier","volume":"28","author":"Sakurada","year":"2003","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108571_bib95","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.118.252155","article-title":"Intravenously administered ganaxolone blocks diazepam-resistant lithium-pilocarpine-induced status epilepticus in rats: comparison with allopregnanolone","volume":"368","author":"Saporito","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","article-title":"Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration","volume":"751","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108571_bib98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/019262330002800111","article-title":"Fluoro-Jade. Novel fluorochromes for detecting toxicant-induced neuronal degeneration","volume":"28","author":"Schmued","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuro.2018.02.018","article-title":"Age-dependent behaviors, seizure severity and neuronal damage in response to nerve agents or the organophosphate DFP in immature and adult rats","volume":"66","author":"Scholl","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2021.108571_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib102","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(99)00114-8","article-title":"Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment","volume":"64","author":"Shih","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2021.108571_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12031-009-9259-7","article-title":"Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication","volume":"40","author":"Shih","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108571_bib109","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108571_bib111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108571_bib112","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/toxsci\/kfx048","article-title":"Spatiotemporal progression and remission of lesions in the rat brain following acute intoxication with diisopropylfluorophosphate","volume":"157","author":"Siso","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2021.108571_bib113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/0748233706th268oa","article-title":"Development of a rat pilocarpine model of seizure\/status epilepticus that mimics chemical warfare nerve agent exposure","volume":"22","author":"Tetz","year":"2006","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.neuropharm.2021.108571_bib114","first-page":"416864","article-title":"Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA-A receptor modulators?","volume":"2012","author":"Vinkers","year":"2012","journal-title":"Adv Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.neuropharm.2021.108571_bib115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the American epilepsy society treatments committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Current"},{"key":"10.1016\/j.neuropharm.2021.108571_bib116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4886(88)90010-6","article-title":"Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam","volume":"101","author":"Walton","year":"1988","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108571_bib117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1167.2008.01929.x","article-title":"The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus","volume":"49","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108571_bib118","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury following acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108571_bib119","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/WNL.43.5.895","article-title":"Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus","volume":"43","author":"Yaffe","year":"1993","journal-title":"Neurology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:12:06Z","timestamp":1758438726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":103,"alternative-id":["S0028390821001258"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108571","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108571"}}